Published in Pharmacoepidemiol Drug Saf on December 01, 2008
Measuring concurrent adherence to multiple related medications. Am J Manag Care (2009) 1.88
Racial/Ethnic and gender gaps in the use of and adherence to evidence-based preventive therapies among elderly Medicare Part D beneficiaries after acute myocardial infarction. Circulation (2013) 1.68
Effect of exposure to evidence-based pharmacotherapy on outcomes after acute myocardial infarction in older adults. J Am Geriatr Soc (2012) 1.58
A systematic review of adherence to cardiovascular medications in resource-limited settings. J Gen Intern Med (2011) 1.33
How Medicare Part D benefit phases affect adherence with evidence-based medications following acute myocardial infarction. Health Serv Res (2013) 0.93
Use of guideline-recommended therapies for heart failure in the Medicare population. Clin Cardiol (2010) 0.87
Disability, race/ethnicity, and medication adherence among Medicare myocardial infarction survivors. Am Heart J (2012) 0.86
Observing versus Predicting: Initial Patterns of Filling Predict Long-Term Adherence More Accurately Than High-Dimensional Modeling Techniques. Health Serv Res (2015) 0.85
Management of new-onset epilepsy in the elderly. Nat Rev Neurol (2009) 0.83
Does the use of an electronic reminder device with or without counseling improve adherence to lipid-lowering treatment? The results of a randomized controlled trial. Front Pharmacol (2013) 0.80
Adherence to common cardiovascular medications in patients with schizophrenia vs. patients without psychiatric illness. Gen Hosp Psychiatry (2015) 0.79
Comparative cost-effectiveness of interventions to improve medication adherence after myocardial infarction. Health Serv Res (2012) 0.79
Helping our patients to adhere to chronic medications: a new arrow for the quiver. J Gen Intern Med (2011) 0.79
Rationale and design of the Study of a Tele-pharmacy Intervention for Chronic diseases to Improve Treatment adherence (STIC2IT): A cluster-randomized pragmatic trial. Am Heart J (2016) 0.78
Prevalent but moderate variation across small geographic regions in patient nonadherence to evidence-based preventive therapies in older adults after acute myocardial infarction. Med Care (2014) 0.77
Understanding patients' perspective of statin therapy: can we design a better approach to the management of dyslipidaemia? A literature review. Singapore Med J (2014) 0.77
Impact of Hospitalization for Acute Myocardial Infarction on Adherence to Statins Among Older Adults. Circ Cardiovasc Qual Outcomes (2016) 0.75
Potentially disruptive life events: what are the immediate impacts on chronic disease management? A case-crossover analysis. BMJ Open (2016) 0.75
Does the association between adherence to statin medications and mortality depend on measurement approach? A retrospective cohort study. BMC Med Res Methodol (2017) 0.75
Ten-year trends in antiretroviral therapy persistence among US Medicaid beneficiaries. AIDS (2017) 0.75
The association between adherence to cardiovascular medications and healthcare utilization. Eur J Health Econ (2015) 0.75
The effect of race on postsurgical ambulatory medical follow-up among United States Veterans. J Clin Anesth (2017) 0.75
Adherence to medication. N Engl J Med (2005) 39.77
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet (2005) 32.41
The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med (1996) 23.76
Cumulative meta-analysis of therapeutic trials for myocardial infarction. N Engl J Med (1992) 17.33
Heart disease and stroke statistics--2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation (2006) 14.72
Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation (2001) 14.70
The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making. JAMA (2000) 12.86
Impact of medication adherence on hospitalization risk and healthcare cost. Med Care (2005) 9.62
The treatment of unrelated disorders in patients with chronic medical diseases. N Engl J Med (1998) 9.19
The assessment of refill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol (1997) 8.88
Interventions to enhance patient adherence to medication prescriptions: scientific review. JAMA (2002) 8.30
Long-term persistence in use of statin therapy in elderly patients. JAMA (2002) 7.19
Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. JAMA (2007) 7.11
Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA (2002) 6.30
Interventions to enhance medication adherence in chronic medical conditions: a systematic review. Arch Intern Med (2007) 4.92
Impact of medication therapy discontinuation on mortality after myocardial infarction. Arch Intern Med (2006) 4.44
Persistence of use of lipid-lowering medications: a cross-national study. JAMA (1998) 4.15
Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease. Circulation (2006) 3.96
Expert consensus document on beta-adrenergic receptor blockers. Eur Heart J (2004) 3.14
Adherence to statin treatment and readmission of patients after myocardial infarction: a six year follow up study. Heart (2002) 2.83
Cost-effectiveness of providing full drug coverage to increase medication adherence in post-myocardial infarction Medicare beneficiaries. Circulation (2008) 2.42
Eulogy for a quality measure. N Engl J Med (2007) 1.86
Should patients receive secondary prevention medications for free after a myocardial infarction? An economic analysis. Health Aff (Millwood) (2007) 1.45
National evaluation of adherence to beta-blocker therapy for 1 year after acute myocardial infarction in patients with commercial health insurance. Am Heart J (2006) 1.43
Secondary prevention of coronary heart disease in older patients after the national service framework: population based study. BMJ (2006) 1.42
Expert consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease. The Task Force on ACE-inhibitors of the European Society of Cardiology. Eur Heart J (2004) 1.25
Medication adherence after myocardial infarction: a long way left to go. J Gen Intern Med (2008) 1.01
Clinical equivalence of generic and brand-name drugs used in cardiovascular disease: a systematic review and meta-analysis. JAMA (2008) 6.63
Association between the choice of IV crystalloid and in-hospital mortality among critically ill adults with sepsis*. Crit Care Med (2014) 5.89
Antidepressant use in pregnancy and the risk of cardiac defects. N Engl J Med (2014) 4.99
Validity of International Classification of Diseases, Ninth Revision, Clinical Modification Codes for Acute Renal Failure. J Am Soc Nephrol (2006) 4.95
Full coverage for preventive medications after myocardial infarction. N Engl J Med (2011) 4.51
The comparative safety of analgesics in older adults with arthritis. Arch Intern Med (2010) 4.47
A combined comorbidity score predicted mortality in elderly patients better than existing scores. J Clin Epidemiol (2011) 3.98
Use of antidepressants near delivery and risk of postpartum hemorrhage: cohort study of low income women in the United States. BMJ (2013) 3.88
Primary medication non-adherence: analysis of 195,930 electronic prescriptions. J Gen Intern Med (2010) 3.57
Online social networking by patients with diabetes: a qualitative evaluation of communication with Facebook. J Gen Intern Med (2010) 3.31
Risk of death associated with the use of conventional versus atypical antipsychotic drugs among elderly patients. CMAJ (2007) 3.30
The implications of therapeutic complexity on adherence to cardiovascular medications. Arch Intern Med (2011) 3.27
Variations in pill appearance of antiepileptic drugs and the risk of nonadherence. JAMA Intern Med (2013) 3.13
Relationship between selective cyclooxygenase-2 inhibitors and acute myocardial infarction in older adults. Circulation (2004) 2.98
Hetastarch and bleeding complications after coronary artery surgery. Chest (2003) 2.87
Nonsteroidal anti-inflammatory drug use and acute myocardial infarction. Arch Intern Med (2002) 2.82
The comparative short-term effectiveness of iron dosing and formulations in US hemodialysis patients. Am J Med (2013) 2.77
The comparative safety of opioids for nonmalignant pain in older adults. Arch Intern Med (2010) 2.71
Comparative mortality risk of anemia management practices in incident hemodialysis patients. JAMA (2010) 2.71
The increasing prevalence of atrial fibrillation among hemodialysis patients. J Am Soc Nephrol (2011) 2.61
Improvements in long-term mortality after myocardial infarction and increased use of cardiovascular drugs after discharge: a 10-year trend analysis. J Am Coll Cardiol (2008) 2.58
Statin adherence and risk of accidents: a cautionary tale. Circulation (2009) 2.47
Cost-effectiveness of providing full drug coverage to increase medication adherence in post-myocardial infarction Medicare beneficiaries. Circulation (2008) 2.42
Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis. Ann Rheum Dis (2010) 2.39
Anti-tumor necrosis factor alpha therapy and the risk of serious bacterial infections in elderly patients with rheumatoid arthritis. Arthritis Rheum (2007) 2.37
Racial differences in screening for prostate cancer in the elderly. Arch Intern Med (2004) 2.34
Helping patients simplify and safely use complex prescription regimens. Arch Intern Med (2011) 2.29
A systematic review of sevelamer in ESRD and an analysis of its potential economic impact in Canada and the United States. Kidney Int (2004) 2.29
Variability in pharmacy interpretations of physician prescriptions. Med Care (2009) 2.18
Treatment of older adult patients diagnosed with rheumatoid arthritis: improved but not optimal. Arthritis Rheum (2007) 2.18
Patterns of medication initiation in newly diagnosed diabetes mellitus: quality and cost implications. Am J Med (2012) 2.13
Assessing health state utilities in elderly patients at cardiovascular risk. Med Decis Making (2006) 2.12
Trouble getting started: predictors of primary medication nonadherence. Am J Med (2011) 2.09
Four-dollar generics--increased accessibility, impaired quality assurance. N Engl J Med (2010) 2.08
Infection risk with bolus versus maintenance iron supplementation in hemodialysis patients. J Am Soc Nephrol (2013) 2.06
Association between Medicare Advantage plan star ratings and enrollment. JAMA (2013) 2.06
Association between the Part D coverage gap and adverse health outcomes. J Am Geriatr Soc (2012) 1.99
Immunosuppressive medications and hospitalization for cardiovascular events in patients with rheumatoid arthritis. Arthritis Rheum (2006) 1.95
The effect of Medicare Part D coverage on drug use and cost sharing among seniors without prior drug benefits. Health Aff (Millwood) (2009) 1.95
Osteoporosis telephonic intervention to improve medication regimen adherence: a large, pragmatic, randomized controlled trial. Arch Intern Med (2012) 1.94
Trends in the use and outcomes of implantable cardioverter-defibrillators in patients undergoing dialysis in the United States. Am J Kidney Dis (2011) 1.92
Measuring concurrent adherence to multiple related medications. Am J Manag Care (2009) 1.88
Preoperative statin use and postoperative acute kidney injury. Am J Med (2012) 1.87
Medication adherence: a call for action. Am Heart J (2011) 1.85
Educational level as a determinant of access to and outcomes after kidney transplantation in the United States. Am J Kidney Dis (2008) 1.84
Modes of delivery for interventions to improve cardiovascular medication adherence. Am J Manag Care (2010) 1.83
Nephrologist care and mortality in patients with chronic renal insufficiency. Arch Intern Med (2002) 1.82
Algorithms to estimate the beginning of pregnancy in administrative databases. Pharmacoepidemiol Drug Saf (2012) 1.81
Value-based insurance design: quality improvement but no cost savings. Health Aff (Millwood) (2013) 1.81
Trends in drug prescribing for osteoporosis after hip fracture, 1995-2004. J Rheumatol (2007) 1.80
Epidemiology and sociodemographics of systemic lupus erythematosus and lupus nephritis among US adults with Medicaid coverage, 2000-2004. Arthritis Rheum (2013) 1.80
Hydroxyethyl starch and change in renal function in patients undergoing coronary artery bypass graft surgery. Kidney Int (2003) 1.80
A propensity analysis of late versus early nephrologist referral and mortality on dialysis. J Am Soc Nephrol (2003) 1.78
Comparative effectiveness of generic and brand-name statins on patient outcomes: a cohort study. Ann Intern Med (2014) 1.78
Explaining the cardiovascular risk associated with rheumatoid arthritis: traditional risk factors versus markers of rheumatoid arthritis severity. Ann Rheum Dis (2010) 1.76
Commentary on 'The DOPPS practice monitor for U.S. dialysis care: update on trends in anemia management 2 years into the bundle': iron(y) abounds 2 years later. Am J Kidney Dis (2013) 1.76
Opioid analgesics and the risk of fractures in older adults with arthritis. J Am Geriatr Soc (2011) 1.76
Relationship between COX-2 specific inhibitors and hypertension. Hypertension (2004) 1.75
Harnessing the Medicaid Analytic eXtract (MAX) to Evaluate Medications in Pregnancy: Design Considerations. PLoS One (2013) 1.74
Delayed nephrologist referral and inadequate vascular access in patients with advanced chronic kidney failure. J Clin Epidemiol (2002) 1.73
Variation in nephrologist visits to patients on hemodialysis across dialysis facilities and geographic locations. Clin J Am Soc Nephrol (2013) 1.69
Trends in the incidence, demographics, and outcomes of end-stage renal disease due to lupus nephritis in the US from 1995 to 2006. Arthritis Rheum (2011) 1.68
Effectiveness and safety of warfarin initiation in older hemodialysis patients with incident atrial fibrillation. Clin J Am Soc Nephrol (2011) 1.67
Seizure outcomes following the use of generic versus brand-name antiepileptic drugs: a systematic review and meta-analysis. Drugs (2010) 1.67
The hepatotoxicity of antifungal medications in bone marrow transplant recipients. Clin Infect Dis (2005) 1.67
Agreement of diagnosis and its date for hematologic malignancies and solid tumors between medicare claims and cancer registry data. Cancer Causes Control (2007) 1.66
Impact of baseline heart failure burden on post-implantable cardioverter-defibrillator mortality among medicare beneficiaries. J Am Coll Cardiol (2013) 1.62
Cost-effectiveness of novel regimens for the treatment of hepatitis C virus. Ann Intern Med (2015) 1.61
Kidney function and use of recommended medications after myocardial infarction in elderly patients. Clin J Am Soc Nephrol (2006) 1.60
Patient, physician, and payment predictors of statin adherence. Med Care (2010) 1.59
False Claims Act prosecution did not deter off-label drug use in the case of neurontin. Health Aff (Millwood) (2011) 1.59
At Pitney Bowes, value-based insurance design cut copayments and increased drug adherence. Health Aff (Millwood) (2010) 1.59
A critical review of FDA-approved Medication Guides. Patient Educ Couns (2006) 1.58
The impact of reducing cardiovascular medication copayments on health spending and resource utilization. J Am Coll Cardiol (2012) 1.58
Trends in anemia care in older patients approaching end-stage renal disease in the United States (1995-2010). JAMA Intern Med (2014) 1.58
Variation in initial kidney replacement therapy for end-stage renal disease due to lupus nephritis in the United States. Arthritis Care Res (Hoboken) (2011) 1.57
Predicting survival in patients requiring renal replacement therapy after cardiac surgery. Ann Thorac Surg (2006) 1.53
Determinants of selective cyclooxygenase-2 inhibitor prescribing: are patient or physician characteristics more important? Am J Med (2003) 1.53
Long-term patient and graft survival in the eurotransplant senior program: a single-center experience. Transplantation (2005) 1.51
Increasing generic drug use in Medicare Part D: the role of government. J Am Geriatr Soc (2007) 1.51
Adherence to statin therapy in elderly patients after hospitalization for coronary revascularization. Am J Cardiol (2011) 1.49
Sudden uncontrollable somnolence and medication use in Parkinson disease. Arch Neurol (2005) 1.48
Preventive health care measures before and after start of renal replacement therapy. J Gen Intern Med (2002) 1.47
Effect of standardized, patient-centered label instructions to improve comprehension of prescription drug use. Med Care (2011) 1.47
The quality of obstructive lung disease care for adults in the United States as measured by adherence to recommended processes. Chest (2006) 1.46
Gender and racial disparities in adherence to statin therapy: a meta-analysis. Am Heart J (2013) 1.46